Sector: Medical Device

Subsector: Treating Allopecia post chemotherapy

Geography: United States

Regulatory status: Class 1 submission


Follisave  is Innovative medical device, designed to prevent chemotherapy induced alopecia (loss of hair). The company is developing a propriety patent-protected technology that will potentially protect 100% of patients from Chemotherapy-Induced Alopecia with no side effects.